| Gene Symbol |
OPTN
|
| Gene Synonyms |
NRP FIP2 HIP7 HYPL ALS12 GLC1E TFIIIA-INTP |
| Gene Full Name |
optineurin |
| Gene Summary |
This gene encodes the coiled-coil containing protein optineurin. Optineurin may play a role in normal-tension glaucoma and adult-onset primary open angle glaucoma. Optineurin interacts with adenovirus E3-14.7K protein and may utilize tumor necrosis factor-alpha or Fas-ligand pathways to mediate apoptosis, inflammation or vasoconstriction. Optineurin may also function in cellular morphogenesis and membrane trafficking, vesicle trafficking, and transcription activation through its interactions with the RAB8, huntingtin, and transcription factor IIIA proteins. Alternative splicing results in multiple transcript variants encoding the same protein. [provided by RefSeq, Jul 2008] |
| Alternative Names |
14.7K interacting protein antibody
Ag9 C5 antibody
ALS12 antibody
E3 14.7K interacting protein antibody
E3-14.7K-interacting protein antibody
FIP 2 antibody
FIP-2 antibody
FIP2 antibody
Glaucoma 1 open angle E (adult onset) antibody
Glaucoma 1 open angle E antibody
GLC1E antibody
HIP 7 antibody
HIP-7 antibody
HIP7 antibody
Huntingtin interacting protein 7 antibody
Huntingtin interacting protein HYPL antibody
Huntingtin interacting protein L antibody
Huntingtin yeast partner L antibody
Huntingtin-interacting protein 7 antibody
Huntingtin-interacting protein L antibody
HYPL antibody
Injury inducible protein I 55 antibody
NEMO related protein antibody
NEMO-related protein antibody
NRP antibody
Optic neuropathy inducing protein antibody
Optic neuropathy-inducing protein antibody
Optineurin antibody
OPTN antibody
OPTN_HUMAN antibody
TFIIIA IntP antibody
TFIIIA-IntP antibody
Transcription factor IIIA interacting protein antibody
Transcription factor IIIA-interacting protein antibody
Tumor necrosis factor alpha inducible cellular protein containing leucine zipper domains antibody |
| Molecular Weight(MW) |
66 kDa |
| Cellular Localization |
Cytoplasm,Cytoplasmic vesicle,Endosome,Golgi apparatus. |